1. Home
  2. BDSX vs PCF Comparison

BDSX vs PCF Comparison

Compare BDSX & PCF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • PCF
  • Stock Information
  • Founded
  • BDSX 2005
  • PCF 1987
  • Country
  • BDSX United States
  • PCF United States
  • Employees
  • BDSX N/A
  • PCF N/A
  • Industry
  • BDSX Precision Instruments
  • PCF Trusts Except Educational Religious and Charitable
  • Sector
  • BDSX Health Care
  • PCF Finance
  • Exchange
  • BDSX Nasdaq
  • PCF Nasdaq
  • Market Cap
  • BDSX 215.3M
  • PCF 196.9M
  • IPO Year
  • BDSX 2020
  • PCF N/A
  • Fundamental
  • Price
  • BDSX $1.07
  • PCF $6.65
  • Analyst Decision
  • BDSX Strong Buy
  • PCF
  • Analyst Count
  • BDSX 4
  • PCF 0
  • Target Price
  • BDSX $3.08
  • PCF N/A
  • AVG Volume (30 Days)
  • BDSX 318.9K
  • PCF 74.8K
  • Earning Date
  • BDSX 02-28-2025
  • PCF 01-01-0001
  • Dividend Yield
  • BDSX N/A
  • PCF 10.90%
  • EPS Growth
  • BDSX N/A
  • PCF N/A
  • EPS
  • BDSX N/A
  • PCF N/A
  • Revenue
  • BDSX $65,562,000.00
  • PCF N/A
  • Revenue This Year
  • BDSX $46.97
  • PCF N/A
  • Revenue Next Year
  • BDSX $31.44
  • PCF N/A
  • P/E Ratio
  • BDSX N/A
  • PCF N/A
  • Revenue Growth
  • BDSX 48.92
  • PCF N/A
  • 52 Week Low
  • BDSX $1.07
  • PCF $5.71
  • 52 Week High
  • BDSX $2.21
  • PCF $6.96
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 30.25
  • PCF 56.08
  • Support Level
  • BDSX $1.09
  • PCF $6.48
  • Resistance Level
  • BDSX $1.51
  • PCF $6.66
  • Average True Range (ATR)
  • BDSX 0.10
  • PCF 0.09
  • MACD
  • BDSX -0.04
  • PCF 0.03
  • Stochastic Oscillator
  • BDSX 0.00
  • PCF 96.00

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About PCF High Income Securities Fund

High Income Securities Fund is a closed-end management investment company. Its primary objective is to provide high current income and capital appreciation is the secondary objective. The Fund pursues its objective primarily by investing in both convertible bonds and convertible preferred stocks. The Fund also invests significantly in high-yielding non-convertible securities with the potential for capital appreciation.

Share on Social Networks: